首页> 美国卫生研究院文献>other >Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of Mesenchymal Stem Cells (MSCs)
【2h】

Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of Mesenchymal Stem Cells (MSCs)

机译:多孔PLGA / PEI1.8k可生物降解微球的开发用于递送间充质干细胞(MSC)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Multipotent mesenchymal stem cells (MSCs) promise a therapeutic alternative for many debilitating and incurable diseases. However, one of the major limitations for the therapeutic application of human MSC (hMSC) is the lengthy ex vivo expansion time for preparing a sufficient amount of cells due to the low engraftment rate after transplantation. To solve this conundrum, a porous biodegradable polymeric microsphere was investigated as a potential scaffold for the delivery of MSCs. The modified water/oil/water (W1/O/W2) double emulsion solvent evaporation method was used for the construction of porous microspheres. PEI1.8k was blended with Poly(lactic-co-glycolic acid) (PLGA) to enhance electrostatic cellular attachment to the microspheres. The porous PLGA/PEI1.8k (PPP) particles demonstrated an average particle size of 290 µm and an average pore size of 14.3 µm, providing a micro-carrier for the MSC delivery. PPP particles allowed for better attachment of rMSCs than nonporous PLGA/PEI1.8k (NPP) particles and non-porous (NP) and porous PLGA (PP) microspheres. rMSC successfully grew on the PPP particles for 2 weeks in vitro. Next, PPP particles loaded with 3 different amounts of hMSC showed increased in vivo engraftment rates and maintained the stemness characteristics of hMSC compared with hMSCs-alone group in rats 2 weeks after intramyocardial administration. These customized PPP particles for MSC delivery are a biodegradable and injectable scaffold that can be used for clinical applications.
机译:多能性间充质干细胞(MSC)有望成为许多使人衰弱和无法治愈的疾病的治疗选择。但是,人MSC(hMSC)的治疗应用的主要限制之一是由于移植后植入率低,制备足够数量细胞的离体扩增时间长。为了解决这个难题,人们研究了一种多孔的可生物降解的聚合物微球,作为一种潜在的递送MSC的支架。采用改进的水/油/水(W1 / O / W2)双乳液溶剂蒸发法制备多孔微球。将PEI1.8k与聚乳酸-乙醇酸共聚物(PLGA)混合,以增强静电细胞对微球的附着。多孔PLGA / PEI1.8k(PPP)颗粒的平均粒径为290 µm,平均孔径为14.3 µm,为MSC输送提供了微载体。与无孔PLGA / PEI1.8k(NPP)颗粒和无孔(NP)和多孔PLGA(PP)微球相比,PPP颗粒可以更好地附着rMSC。 rMSC在PPP颗粒上成功生长了2周。接着,与单独使用hMSCs的组相比,在心肌内给药后2周,装载有3种不同量的hMSC的PPP颗粒显示出体内的植入率增加并且保持了hMSC的干性特征。这些用于MSC递送的定制PPP颗粒是可生物降解和可注射的支架,可用于临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号